神经炎症
自噬
神经退行性变
小胶质细胞
多发性硬化
吞噬作用
髓鞘
生物
免疫学
细胞生物学
炎症
中枢神经系统
神经科学
医学
疾病
病理
生物化学
细胞凋亡
作者
Rasmus Berglund,André Ortlieb Guerreiro‐Cacais,Milena Z. Adzemovic,Manuel Zeitelhofer,Harald Lund,Ewoud Ewing,Stephan Ruhrmann,Erik Nutma,Roham Parsa,Melanie Thessen-Hedreul,Sandra Amor,Robert A. Harris,Tomas Olsson,Maja Jagodic
出处
期刊:Science immunology
[American Association for the Advancement of Science (AAAS)]
日期:2020-10-08
卷期号:5 (52)
被引量:100
标识
DOI:10.1126/sciimmunol.abb5077
摘要
Multiple sclerosis (MS) is a leading cause of incurable progressive disability in young adults caused by inflammation and neurodegeneration in the central nervous system (CNS). The capacity of microglia to clear tissue debris is essential for maintaining and restoring CNS homeostasis. This capacity diminishes with age, and age strongly associates with MS disease progression, although the underlying mechanisms are still largely elusive. Here, we demonstrate that the recovery from CNS inflammation in a murine model of MS is dependent on the ability of microglia to clear tissue debris. Microglia-specific deletion of the autophagy regulator Atg7, but not the canonical macroautophagy protein Ulk1, led to increased intracellular accumulation of phagocytosed myelin and progressive MS-like disease. This impairment correlated with a microglial phenotype previously associated with neurodegenerative pathologies. Moreover, Atg7-deficient microglia showed notable transcriptional and functional similarities to microglia from aged wild-type mice that were also unable to clear myelin and recover from disease. In contrast, induction of autophagy in aged mice using the disaccharide trehalose found in plants and fungi led to functional myelin clearance and disease remission. Our results demonstrate that a noncanonical form of autophagy in microglia is responsible for myelin degradation and clearance leading to recovery from MS-like disease and that boosting this process has a therapeutic potential for age-related neuroinflammatory conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI